PH12015502150A1 - Citrate containing beverage - Google Patents

Citrate containing beverage

Info

Publication number
PH12015502150A1
PH12015502150A1 PH12015502150A PH12015502150A PH12015502150A1 PH 12015502150 A1 PH12015502150 A1 PH 12015502150A1 PH 12015502150 A PH12015502150 A PH 12015502150A PH 12015502150 A PH12015502150 A PH 12015502150A PH 12015502150 A1 PH12015502150 A1 PH 12015502150A1
Authority
PH
Philippines
Prior art keywords
beverage compositions
containing beverage
citrate containing
urine
beverage
Prior art date
Application number
PH12015502150A
Other languages
English (en)
Inventor
David S Goldfarb
Eisner Brian
Asplin John
Marshall L Stoller
Original Assignee
Univ California
Univ New York
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Univ New York, Gen Hospital Corp filed Critical Univ California
Publication of PH12015502150A1 publication Critical patent/PH12015502150A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/68—Acidifying substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PH12015502150A 2013-03-15 2015-09-15 Citrate containing beverage PH12015502150A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361793442P 2013-03-15 2013-03-15
PCT/US2014/027736 WO2014152789A1 (en) 2013-03-15 2014-03-14 Citrate containing beverage

Publications (1)

Publication Number Publication Date
PH12015502150A1 true PH12015502150A1 (en) 2016-01-25

Family

ID=51528113

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12015502150A PH12015502150A1 (en) 2013-03-15 2015-09-15 Citrate containing beverage

Country Status (11)

Country Link
US (4) US9278112B2 (enExample)
EP (1) EP2983783B1 (enExample)
JP (1) JP6581564B2 (enExample)
CN (1) CN105209120A (enExample)
AU (1) AU2014236553B2 (enExample)
BR (1) BR112015023495A8 (enExample)
CA (1) CA2906907C (enExample)
HK (1) HK1219070A1 (enExample)
MX (1) MX352660B (enExample)
PH (1) PH12015502150A1 (enExample)
WO (1) WO2014152789A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014152789A1 (en) * 2013-03-15 2014-09-25 New York University Citrate containing beverage
US11273140B2 (en) 2013-06-06 2022-03-15 Stefanie A. Seixas-Mikelus Juice beverage for prevention and treatment of renal stones
ES2486441B1 (es) * 2014-04-02 2015-06-11 Universitat De Les Illes Balears Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico
WO2016159897A1 (en) * 2015-04-01 2016-10-06 Ay Doğan Potassium citrate suspension
US20170035800A1 (en) * 2015-08-06 2017-02-09 Kenneth Davin Fine Reduction of Oxalate Absorption in Individuals
JP6714984B2 (ja) * 2015-08-31 2020-07-01 キリンビバレッジ株式会社 クエン酸由来の異味が低減された容器詰めクエン酸高含有酸性飲料
EP3532083A4 (en) * 2016-10-27 2020-07-22 Seixas-Mikelus, Stefanie, A. JUICE-BASED DRINK TO PREVENT AND TREAT RENAL CALCULATIONS
CN108125232A (zh) * 2017-03-07 2018-06-08 浙江欣诺医药有限公司 预防与治疗泌尿系结石的补充剂及其制备方法和应用
US11259553B2 (en) 2017-08-22 2022-03-01 Litholyte Corporation, Llc Dietary supplementation with mixed alkali salts
CA3015055A1 (en) 2017-08-22 2019-02-22 Ryan Holland Dietary supplementation with mixed alkali salts
CN108887682A (zh) * 2018-06-09 2018-11-27 夏志君 柠檬酸钠制成柠檬酸钠养生粉及其应用
AU2021257176A1 (en) * 2020-04-14 2022-11-10 Nippon Chemiphar Co., Ltd. Sleep quality improver

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU165181B (enExample) * 1971-11-08 1974-07-27
US4966776A (en) * 1983-04-11 1990-10-30 Board Of Regents, The University Of Texas System Compositions and methods of treating calcium renal stones
CN1033349A (zh) * 1987-11-28 1989-06-14 王龙祥 可乐系列饮料的制法
US4985593A (en) 1988-01-05 1991-01-15 Mission Pharmacal Company, Inc. Magnesium potassium citrate
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
US5085883A (en) * 1991-06-27 1992-02-04 Abbott Laboratories Blend of dietary fiber for nutritional products
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US20010002269A1 (en) 1997-05-06 2001-05-31 Zhao Iris Ginron Multi-phase food & beverage
BR0111292A (pt) 2000-06-02 2003-06-10 Procter & Gamble Composições com baixo teor de carboidrato, kits destas e métodos de uso
CN1284303A (zh) * 2000-09-08 2001-02-21 徐华春 治疗结石的饮料
US20030203072A1 (en) * 2002-04-26 2003-10-30 Team Nrg, Inc. Rehydration beverage
US20050100637A1 (en) 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
US7323201B2 (en) 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US20050276839A1 (en) * 2004-06-10 2005-12-15 Rifkin Calman H Appetite satiation and hydration beverage
US7205018B2 (en) 2004-10-07 2007-04-17 Next Proteins, Inc. Carbonated protein drink and method of making
US7897192B2 (en) 2004-10-07 2011-03-01 Next Proteins, Inc. High energy carbonated protein drink and method of making
US20070077314A1 (en) 2005-07-15 2007-04-05 Pak Charles Y C Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
JP5349744B2 (ja) * 2005-12-19 2013-11-20 松谷化学工業株式会社 ミネラル吸収促進剤、食品及び飼料
RU2475031C2 (ru) * 2007-05-18 2013-02-20 Мид Джонсон Нутришен Компани Подкисленная жидкая добавка к грудному молоку
GB201012539D0 (en) 2010-07-27 2010-09-08 Savantium Ltd Nutritional compositions
AU2011329715A1 (en) 2010-11-18 2013-06-06 The Coca-Cola Company Performance enhancing sports beverage and methods of use
WO2014152789A1 (en) * 2013-03-15 2014-09-25 New York University Citrate containing beverage

Also Published As

Publication number Publication date
HK1219070A1 (zh) 2017-03-24
US9895396B2 (en) 2018-02-20
CA2906907A1 (en) 2014-09-25
US20140271929A1 (en) 2014-09-18
MX2015013221A (es) 2016-04-15
JP6581564B2 (ja) 2019-09-25
AU2014236553B2 (en) 2019-01-17
US20160184349A1 (en) 2016-06-30
US20180169144A1 (en) 2018-06-21
EP2983783A4 (en) 2016-10-26
BR112015023495A2 (pt) 2017-07-18
WO2014152789A1 (en) 2014-09-25
CA2906907C (en) 2021-04-13
US20170340664A1 (en) 2017-11-30
BR112015023495A8 (pt) 2019-12-03
MX352660B (es) 2017-12-04
EP2983783B1 (en) 2021-04-21
AU2014236553A1 (en) 2015-11-05
CN105209120A (zh) 2015-12-30
EP2983783A1 (en) 2016-02-17
JP2016513474A (ja) 2016-05-16
US10258645B2 (en) 2019-04-16
US9278112B2 (en) 2016-03-08
US9737564B2 (en) 2017-08-22

Similar Documents

Publication Publication Date Title
PH12015502150A1 (en) Citrate containing beverage
DK3349763T3 (en) Composition for use in microbiota modulation
EP3054940A4 (en) Compositions and methods for treating non-alcoholic steatohepatitis
SG11201507288UA (en) Compositions and methods for treating non-alcoholic steatohepatitis
PH12015502659A1 (en) Surface treatment compositions comprising photochromic dyes
EP3054953A4 (en) Hdac inhibitors, alone or in combination with pi3k inhibitors, for treating non-hodgkin's lymphoma
IL241191B (en) Local compositions and kits that include them for the treatment of local disorders
EP3054954A4 (en) Hdac inhibitors, alone or in combination with btk inhibitors, for treating non-hodgkin's lymphoma
IL259836B (en) Dimeric macrocyclic cations, complexes containing them and their uses as contrast agents
ZA201707114B (en) Methods for detecting agglutination and compositions for use in practicing the same
IL241823B (en) Preparations containing novyi .c and their uses for the treatment of cancerous tumors
MX2016004802A (es) Anticuerpos anti-r-espondina (anti-rspo) y metodos de uso.
EP3055377A4 (en) Wet-process ceria compositions for selectively polishing substrates, and methods related thereto
MX2015009818A (es) Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerosis multiple.
WO2015179598A3 (en) Systems and methods for exchange of buffer solutions
EP3031245A4 (en) Bs and ue, and interference cancellation methods used in the same
ZA201506330B (en) Methods and compositions for treating leukemia
MX2015010023A (es) Anticuerpos anti-cd83 y su uso.
PL3076834T3 (pl) Maszyna do przygotowywania napojów oraz sposób eksploatacji maszyny do przygotowywania napojów
EP3234927A4 (en) Taximeter for use in vehicles and method for the same
GB201421661D0 (en) Method for determining the concentration of iron ions in hydrocarbon compositions
WO2014160628A3 (en) Articles and methods for preventing and treating dermatologic adverse events
MX2017008612A (es) Películas envolventes con opacidad aumentada.
EP3249987A4 (en) Method and device for use in enhancing carrier aggregation
PT3068863T (pt) Processo dinâmico de eliminação parcial ou total de compostos organoalogenados contidos em bebidas, nomeadamente no vinho